The University of Chicago Header Logo

Connection

Larry Goldstein to Follow-Up Studies

Back to Details
This is a "connection" page, showing publications Larry Goldstein has written about Follow-Up Studies.
Larry Goldstein
Connection Strength
0.289
Follow-Up Studies
  1. Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2009 Nov; 40(11):3526-31.
    View in: PubMed
    Score: 0.053
  2. Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial. J Am Coll Cardiol. 2020 05 05; 75(17):2110-2118.
    View in: PubMed
    Score: 0.028
  3. Postmenopausal hormone replacement therapy: effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation. J Clin Oncol. 1999 Jun; 17(6):1680-8.
    View in: PubMed
    Score: 0.026
  4. Reliability and validity of the SA-45: further evidence from a primary care setting. Assessment. 1998 Dec; 5(4):407-19.
    View in: PubMed
    Score: 0.025
  5. Statins and the Risk of Intracerebral Hemorrhage in Patients With Previous Ischemic Stroke or Transient Ischemic Attack. Stroke. 2017 12; 48(12):3245-3251.
    View in: PubMed
    Score: 0.023
  6. Sample size calculations for clinical trials using the NIH Stroke Scale. Stroke. 1994 Aug; 25(8):1700-1.
    View in: PubMed
    Score: 0.019
  7. Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. Stroke. 2014 May; 45(5):1429-36.
    View in: PubMed
    Score: 0.018
  8. Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trial. J Stroke Cerebrovasc Dis. 2014 Apr; 23(4):778-84.
    View in: PubMed
    Score: 0.018
  9. Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial. Stroke. 2013 Oct; 44(10):2688-93.
    View in: PubMed
    Score: 0.017
  10. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology. 2011 Sep 20; 77(12):1182-90.
    View in: PubMed
    Score: 0.015
  11. Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2010 Mar; 41(3):426-30.
    View in: PubMed
    Score: 0.014
  12. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2007 Dec; 38(12):3198-204.
    View in: PubMed
    Score: 0.012
  13. Gram-Negative anaerobic endocarditis: two case reports and review of the literature. Eur J Clin Microbiol Infect Dis. 2001 Sep; 20(9):651-4.
    View in: PubMed
    Score: 0.008
  14. Improved outcome after intestinal transplantation: an 8-year, single-center experience. Transplant Proc. 2000 Sep; 32(6):1233-4.
    View in: PubMed
    Score: 0.007
  15. Transjugular intrahepatic portosystemic shunts: impact on liver transplantation. Liver Transpl Surg. 1995 Jul; 1(4):229-33.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.